European CLOs Hampered By Capital Treatment
The supply of European collateralized loan obligations is being hampered in part by regulatory capital treatment, with investors concerned about taking exposure to European corporate risk through CLOs linked to small and medium-size enterprises, according to Fitch Ratings.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
